WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Loiasis Cross-reactive Antigenemia and Treatment-related Adverse Events
- First Posted Date
- 2021-10-20
- Last Posted Date
- 2022-09-29
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 41
- Registration Number
- NCT05085665
- Locations
- 🇨🇲
Centre de Recherche sur les Filarioses et autres Maladies Tropicales (CRFilMT), Yaoundé, Cameroon
Effects of Microplegia on Transfusion Rates After Cardiac Surgery
- Conditions
- Aortic Valve DiseaseMitral Valve Disease
- Interventions
- Drug: Cardioplegia SolutionDrug: Microplegic Solution No. 1
- First Posted Date
- 2021-10-13
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 314
- Registration Number
- NCT05076604
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Amygdala Memory Enhancement
- Conditions
- Post Traumatic Stress DisorderTraumatic Brain InjuryEpilepsyMemory DisordersBrain DiseasesCognitive Impairment
- Interventions
- Device: Intracranial Stimulation
- First Posted Date
- 2021-10-04
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 90
- Registration Number
- NCT05065450
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection
- Conditions
- Stage II Melanoma
- Interventions
- First Posted Date
- 2021-09-28
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 7
- Registration Number
- NCT05060003
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
DM DEVICE DISRUPTION SURVEY
- Conditions
- Diabetes Mellitus
- First Posted Date
- 2021-09-20
- Last Posted Date
- 2021-09-20
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 300
- Registration Number
- NCT05050019
- Locations
- 🇺🇸
Washington University, Barnes Jewish Hospital, Saint Louis, Missouri, United States
Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial)
- Conditions
- Small-cell Lung CancerSmall Cell Lung Carcinoma
- Interventions
- First Posted Date
- 2021-09-20
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 17
- Registration Number
- NCT05049863
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Imaging Apoptosis for Lymphoma Treatment Response
- First Posted Date
- 2021-09-17
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 12
- Registration Number
- NCT05048732
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy
- Conditions
- Non-hodgkin LymphomaAcute Lymphocytic Leukemia
- Interventions
- First Posted Date
- 2021-09-14
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 43
- Registration Number
- NCT05044039
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Perioperative Outcome Risk Assessment With Computer Learning Enhancement
- Conditions
- Acute Kidney InjuryMorality
- Interventions
- Other: Machine learning models predicting postoperative death and acute kidney injury
- First Posted Date
- 2021-09-13
- Last Posted Date
- 2022-11-14
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 5114
- Registration Number
- NCT05042804
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1
- Conditions
- Clonal Cytopenia of Undetermined Significance
- Interventions
- First Posted Date
- 2021-09-01
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT05030441
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸Northwell Health Cancer Institute (R.J. Zuckerberg Cancer Center), Lake Success, New York, United States
🇺🇸Memorial Sloan Kettering, New York, New York, United States